Shenzhen Hepalink Pharmaceutical Group Co. Mergers & Acquisitions

Shenzhen Hepalink Pharmaceutical Group Co. M&A Summary

Shenzhen Hepalink Pharmaceutical Group Co. has acquired 3 companies. A total of 3 acquisitions came from private equity firms.

Shenzhen Hepalink Pharmaceutical Group Co.’s largest acquisition to date was in 2014, when it acquired Scientific Protein Laboratories for $338M. Shenzhen Hepalink Pharmaceutical Group Co. has acquired in 2 different US states. The Company’s most targeted sectors include life science (100%).

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity2
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 3

Shenzhen Hepalink Pharmaceutical Group Co.

Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

No. 21 Langshan Road Songpingshan Nanshan District,
Shenzhen, 518057
China,
+86 755 2698 0200
www.hepalink.com

All (2) Buy (2) Sell (-)
Date Target Value
$mlns
Transaction Type Acquirer Seller SRC
Link
2015-08-24 Cytovance Biologics, Inc. · Life Science
Oklahoma City, Oklahoma · www.cytovance.com

Cytovance is a contract manufacturing organization of mammalian and microbial biologics. The company works with biotechnology and pharmaceutical companies in the development and manufacturing of proteins, antibodies, and cell-based therapeutic products. Cytovance supports its customers from clinical development to commercial launch in domestic and international markets.

Advisor: Wells Fargo Securities
206 Add-on Acquisition

Shenzhen Hepalink Pharmaceutical Group Co.

Great Point Partners PE

Monroe Capital PE

-

Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.